Sickle Cell Disease With Vaso-Occlusive Crisis (Hematology) - Drugs in Development, 2021

Published	Pages	Publisher	Report code
Sep 2021	72	Global Markets Direct	ASDR-591785

Published: Sep 2021 - Pages : 72 - Publisher : Global Markets Direct - Report code : ASDR-591785

Asklepion Pharmaceuticals LLC
Chugai Pharmaceutical Co Ltd
Cyclerion Therapeutics Inc
Global Blood Therapeutics Inc
GlycoMimetics Inc
Hartis Pharma SA
KM Biologics Co Ltd
NicOx SA
Novartis AG
Prolong Pharmaceuticals LLC

Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key P...

Published: September, 2022 | Report code: ASDR-610410